Outstanding result for Vetter at the 2022 CMO Leadership Awards

As a competent and reliable partner, Vetter makes a significant contribution to the supply of patients with vital medications. © Vetter Pharma International GmbH

The victory at the CMO Leadership Awards 2022 in all six main categories as well as the Champion status in three categories is an outstanding success for Vetter. © Vetter Pharma International GmbH

– Repeated top performance in important customer-relevant service areas
– The result confirms the company's daily commitment with a customer-oriented strategy
– High ranking reflects positive customer experiences in collaboration

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), was awarded this year in all six main categories of the 2022 CMO Leadership Awards: Quality, Portfolio, Service, Expertise, Compatibility, and Reliability. Additionally, Vetter achieved Champion status in the areas of Quality, Expertise, and Compatibility. The award from the leading trade magazine Life Science Leader has been presented for the eleventh time. Due to the ongoing Covid-19 pandemic, the award ceremony will take place virtually in early March.

“Our performance this year is a tremendous success for our entire company,” said Vetter CEO Peter Sölkner enthusiastically. “Winning in all six main categories is already an impressive achievement. The additional recognition as a Champion in the areas of Quality, Expertise, and Compatibility is extraordinary and reflects the daily dedication and valuable work of our 5,700 employees across three continents.” Carsten Press, Vetter's Senior Vice President of Key Account Management / Supply Chain Management / Marketing, added: “This award demonstrates our continuous efforts to meet or exceed our customers' expectations worldwide. The award recognizes and affirms our approach of acting as a competent and trustworthy partner, making a significant contribution to supplying patients worldwide with vital medicines.”

The CMO Leadership Awards program is unique among industry awards because winners are selected based on customer evaluations. These evaluations are based on the collaboration between customers and their partners over the past 18 months. Therefore, the results cannot be influenced in any way and truly represent the actual performance level in customer relationships.

“For companies in our industry that want to achieve optimal results with their outsourcing activities, this award has been very helpful and valuable for more than a decade. Our research division, Industry Standard Research (ISR), exclusively surveys pharmaceutical and biotech companies that have worked with specific CDMOs in recent months. This approach emphasizes and ensures the significance of the results: our award winners can rightfully be called outsourcing champions,” said Louis Garguilo, Editor-in-Chief of the sponsoring trade magazine Outsourced Pharma.